Haemonetics Corp
HAE50.600USD
-0.550-1.08%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
2.44BMarktkapitalisierung
14.92KGV TTM
mehr Informationen über Haemonetics Corp Unternehmen
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Unternehmensinformationen
BörsenkürzelHAE
Name des UnternehmensHaemonetics Corp
IPO-datumOct 17, 1979
CEOMr. Christopher A. Simon
Anzahl der mitarbeiter3023
WertpapierartOrdinary Share
GeschäftsjahresendeOct 17
Addresse125 Summer Street
StadtBOSTON
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl02110
Telefon17818487100
Websitehttps://www.haemonetics.com
BörsenkürzelHAE
IPO-datumOct 17, 1979
CEOMr. Christopher A. Simon
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.39K
--
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.01B
74.29%
Europe
175.66M
12.91%
Asia
92.31M
6.78%
Japan
62.41M
4.59%
other
19.54M
1.44%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, Aug 27
Aktualisiert: Wed, Aug 27
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.56%
The Vanguard Group, Inc.
10.26%
Neuberger Berman, LLC
8.88%
Wellington Management Company, LLP
4.46%
State Street Global Advisors (US)
3.91%
Andere
60.94%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.56%
The Vanguard Group, Inc.
10.26%
Neuberger Berman, LLC
8.88%
Wellington Management Company, LLP
4.46%
State Street Global Advisors (US)
3.91%
Andere
60.94%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.55%
Investment Advisor/Hedge Fund
49.82%
Hedge Fund
5.32%
Research Firm
4.12%
Bank and Trust
1.39%
Pension Fund
1.35%
Individual Investor
1.19%
Sovereign Wealth Fund
1.11%
Insurance Company
0.04%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
2023Q1
715
51.58M
102.24%
-8.44M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
5.67M
11.79%
+31.09K
+0.55%
Mar 31, 2025
The Vanguard Group, Inc.
5.09M
10.59%
-80.50K
-1.56%
Mar 31, 2025
Neuberger Berman, LLC
4.35M
9.05%
-70.98K
-1.61%
Mar 31, 2025
Wellington Management Company, LLP
2.62M
5.46%
-1.32M
-33.38%
Mar 31, 2025
State Street Global Advisors (US)
1.92M
3.99%
-28.97K
-1.49%
Mar 31, 2025
River Road Asset Management, LLC
1.40M
2.9%
+1.04M
+295.76%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
2.20M
4.57%
-358.25K
-14.03%
Mar 31, 2025
Royce Investment Partners
1.16M
2.42%
+8.03K
+0.70%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.22M
2.54%
+40.32K
+3.41%
Mar 31, 2025
Capital Research Global Investors
1.58M
3.28%
-2.66M
-62.79%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Harbor Human Capital Factor US Small Cap ETF
1.78%
SPDR S&P Health Care Equipment ETF
1.45%
First Trust Small Cap Growth AlphaDEX Fund
0.28%
Fidelity Small-Mid Multifactor ETF
0.15%
Global X Russell 2000 ETF
0.15%
Vanguard S&P Mid-Cap 400 Growth Index Fund
0.14%
Invesco Dynamic Buyback Achievers ETF
0.12%
Nuveen ESG Small-Cap ETF
0.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.11%
SPDR S&P 400 Mid Cap Growth ETF
0.1%
Mehr Anzeigen
Harbor Human Capital Factor US Small Cap ETF
Anteil1.78%
SPDR S&P Health Care Equipment ETF
Anteil1.45%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.28%
Fidelity Small-Mid Multifactor ETF
Anteil0.15%
Global X Russell 2000 ETF
Anteil0.15%
Vanguard S&P Mid-Cap 400 Growth Index Fund
Anteil0.14%
Invesco Dynamic Buyback Achievers ETF
Anteil0.12%
Nuveen ESG Small-Cap ETF
Anteil0.11%
Vanguard S&P Mid-Cap 400 Value Index Fund
Anteil0.11%
SPDR S&P 400 Mid Cap Growth ETF
Anteil0.1%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
